Bacil Pharma Ltd vs Tyche Industries Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 03, 2026

Key Highlights

The Latest Trading Price of Bacil Pharma Ltd is ₹ 56.95 as of 30 Apr 15:30 . The P/E Ratio of Bacil Pharma Ltd changed from 146.5 on March 2025 to 146.5 on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of Tyche Industries Ltd changed from 8.7 on March 2021 to 11 on March 2025 . This represents a CAGR of 4.80% over 5 years The Market Cap of Bacil Pharma Ltd changed from ₹ 1.84 crore on March 2021 to ₹ 60.99 crore on March 2025 . This represents a CAGR of 101.41% over 5 yearsThe Market Cap of Tyche Industries Ltd changed from ₹ 174.66 crore on March 2021 to ₹ 136.38 crore on March 2025 . This represents a CAGR of -4.83% over 5 years The revenue of Bacil Pharma Ltd for the Dec '25 is ₹ 0.06 crore as compare to the Sep '25 revenue of ₹ 0.05 crore. This represent the growth of 20% The revenue of Tyche Industries Ltd for the Dec '25 is ₹ 12.43 crore as compare to the Sep '25 revenue of ₹ 16.81 crore. This represent the decline of -26.06% The ebitda of Bacil Pharma Ltd for the Dec '25 is ₹ 0.04 crore as compare to the Sep '25 ebitda of ₹ 0.02 crore. This represent the growth of 100% The ebitda of Tyche Industries Ltd for the Dec '25 is ₹ 2.94 crore as compare to the Sep '25 ebitda of ₹ 2.52 crore. This represent the growth of 16.67% The net profit of Bacil Pharma Ltd changed from ₹ -0.03 crore to ₹ 0.04 crore over 7 quarters. This represents a CAGR of NaN% The net profit of Tyche Industries Ltd changed from ₹ 2.73 crore to ₹ 1.82 crore over 7 quarters. This represents a CAGR of -20.68% The Dividend Payout of Bacil Pharma Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Tyche Industries Ltd changed from 5.13 % on March 2021 to 24.78 % on March 2025 . This represents a CAGR of 37.02% over 5 years .

About Bacil Pharma Ltd

Incorporated as a private limited company in Maharashtra in May '87, Bacil Pharma (BPL) was converted into a public limited company in Oct.'90.
The main business activity of the Company is Pharmaceutical. Bal Pharma is a fully integrated and leading Indian pharmaceutical company specialized in Prescription drugs, Branded Formulations, APIs, Generic & OTC products, Intravenous Infusions and Bulk Drugs.
Domestic operations are spread across pan India.
The company has strong field force of 500 plus, spread over various States and Districts.
It has a strong distribution set up, with Super Stockist in all the States and stockists for retail coverage.

About Tyche Industries Ltd

Tyche Industries Limited (formerly known as Siris Soft Limited) was incorporated on Jul' 23, 1998.
TIL is one of the largest manufacturers in India of Glucosamine Hydrochloride and corresponding sodium and potassium salts which are mainly exported to USA and Europe.
Company's operations are predominantly related to the manufacture of bulk drugs intermediates. The company has established two advanced development centers in the area of e-commerce in New Jersey, USA and Hyderabad.
The company has three business models namely offshore solutions, offsite solutions and onsite solutions.
It has entered into strategic alliance with Allegheny Digital Corp, Organic Online Inc, Transaction Information System Inc, CMC and Business Software Solutions Inc. The company is coming with a public issue of 26 lac equity shares of Rs.

FAQs for the comparison of Bacil Pharma Ltd and Tyche Industries Ltd

Which company has a larger market capitalization, Bacil Pharma Ltd or Tyche Industries Ltd?

Market cap of Bacil Pharma Ltd is 81 Cr while Market cap of Tyche Industries Ltd is 125 Cr

What are the key factors driving the stock performance of Bacil Pharma Ltd and Tyche Industries Ltd?

The stock performance of Bacil Pharma Ltd and Tyche Industries Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Bacil Pharma Ltd and Tyche Industries Ltd?

As of May 3, 2026, the Bacil Pharma Ltd stock price is INR ₹56.95. On the other hand, Tyche Industries Ltd stock price is INR ₹122.92.

How do dividend payouts of Bacil Pharma Ltd and Tyche Industries Ltd compare?

To compare the dividend payouts of Bacil Pharma Ltd and Tyche Industries Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.